Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-19-050169

Options or other derivatives

  • Director acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Svoronos Dawn Director 2019-09-16 Grant or award · Stock Option (Right to Buy) +15,000 15,000 D
Loading xslF345X03/doc4.xml…